Johnson & Johnson

NYSE:JNJ   3:59:59 PM EDT
-0.03 (-0.02%)
5:00:36 PM EDT: $137.10 -0.06 (-0.04%)
Earnings Announcements

Johnson & Johnson Enters Agreement With GRAM To Manufacture SARS-CoV-2 Vaccine Candidate

Published: 09/25/2020 13:14 GMT
Johnson & Johnson (JNJ) - Grand River Aseptic Manufacturing - Entered Agreement With Janssen Pharmaceuticals to Support Manufacture of Its Sars-cov-2 Vaccine Candidate.
Grand River Aseptic Manufacturing - Agreement Includes Technical Transfer & Fill and Finish Manufacture of J&j's Sars-cov-2 Vaccine Candidate.
Revenue is expected to be $21.7 Billion
Adjusted EPS is expected to be $1.84

Next Quarter Revenue Guidance is expected to be $21.65 Billion
Next Quarter EPS Guidance is expected to be $2.21

More details on our Analysts Page.